Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 5594545884
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/13 06:42.
Drug filings
21 acceptance records as first applicant, grouped into 13 source drug names. Source data as of 2026/11/13 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
壮腰健肾丸 · No verified English name 1 records · Latest accepted 2026/09/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604480 | Supplement | 2026/09/02 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
当归补血丸 · No verified English name 1 records · Latest accepted 2026/07/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2603528 | Supplement | 2026/07/20 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2026/06/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601258 | Generic | 2026/06/02 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
锁阳固精丸 · No verified English name 2 records · Latest accepted 2026/04/10
Supplement · 2
壮腰健身丸 · No verified English name 2 records · Latest accepted 2026/04/03
Supplement · 2
十二乌鸡白凤丸 · No verified English name 2 records · Latest accepted 2026/02/13
Supplement · 2
肾宝糖浆 · No verified English name 1 records · Latest accepted 2026/02/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2600610 | Supplement | 2026/02/13 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 2 records · Latest accepted 2025/12/29
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504456 | Generic | 2025/12/29 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2504455 | Generic | 2025/12/29 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
补肾丸 · No verified English name 2 records · Latest accepted 2025/07/28
Supplement · 2
阿胶益寿口服液 · No verified English name 1 records · Latest accepted 2025/06/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2501149 | Supplement | 2025/06/12 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
乳宁丸 · No verified English name 1 records · Latest accepted 2025/04/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2500718 | Supplement | 2025/04/16 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
复方乌鸡口服液 · No verified English name 2 records · Latest accepted 2024/09/25
Supplement · 2
Palbociclib Capsules 3 records · Latest accepted 2023/03/07
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300713 | Generic | 2023/03/07 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2300712 | Generic | 2023/03/07 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2300711 | Generic | 2023/03/07 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/16 to 2026/11/13. CDE data as of 2026/11/13 06:42; NMPA data as of 2026/11/12 18:32.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 1 applicationNo longer listed under review: 1 applicationSupplement delivery: 1 application
- 2026/11/04No longer listed under review
当归补血丸 · No verified English name
CYZB2603528
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2026/07/20
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 28
NMPA · Table row 28 ↗ View source ↗ - 2026/11/02Supplement delivery
当归补血丸 · No verified English name
CYZB2603528
Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 28 ↗ - 2026/09/02Accepted
壮腰健肾丸 · No verified English name
CYZB2604480
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗
Under review
3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/13 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 壮腰健肾丸 · No verified English name | CYZB2604480 | Supplement | 2026/09/02 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2504456 | Generic | 2025/12/29 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2504455 | Generic | 2025/12/29 | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
3 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/13 06:39. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Palbociclib Capsules | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | 国药准字H20249263 | 2024/11/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | 国药准字H20249264 | 2024/11/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized | Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | 国药准字H20249262 | 2024/11/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/13 06:41.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/13 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
- Full API register
- Last successful update: 2026/11/13 06:41
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.